Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Why Pure Storage, VirnetX Holding, and Organogenesis Holdings Slumped Today

By Dan Caplinger - Nov 22, 2019 at 4:31PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Find out what punished these unfortunate stocks.

The stock market kept plugging along on Friday, drifting throughout much of the session as investors seemed content to remain patient for a resolution on certain key issues. In that environment, market participants paid a lot of attention to individual companies, looking for hints about the health of certain sectors of the economy. Some stocks posted substantial declines, and Pure Storage ( PSTG 0.00% ), VirnetX Holding ( VHC 0.37% ), and Organogenesis Holdings ( ORGO -0.83% ) were among the worst performers. Here's why they did so poorly.

Pure Storage can't make the grade

Shares of Pure Storage fell 15% after the data solutions specialist reported its third-quarter financial results. Revenue rose 15% from the year-earlier period, with several product releases that aimed to help its clients make better use of their data via cloud-computing platforms. Yet losses widened from a year ago, and Pure Storage wasn't able to produce bottom-line growth even on an adjusted basis. More importantly, the rate of growth wasn't as high as shareholders had wanted to see. Pure Storage's guidance for the fourth quarter and the rest of the year also raised some concerns, and that made growth-oriented investors less comfortable with the company's prospects.

Pure Storage corporate logo in orange and black.

Image source: Pure Storage.

VirnetX has to start over

Licensing specialist VirnetX Holding saw its shares plunge 34% following an adverse decision in a key court case. VirnetX has been engaged in a long legal battle against Apple concerning alleged patent infringement in technology found in various iPhone models. A jury had previously found that Apple would need to pay about $503 million to VirnetX in the infringement case, but an appeals court on Friday set aside that calculation on a couple of key patents. That means that VirnetX will have to go through another trial to move forward, thwarting shareholders who had hoped to finally get a big windfall from the patent litigation.

Organogenesis sells some stock

Finally, Organogenesis' stock plummeted 22%. The regenerative medicine specialist said that it would sell 9 million shares at a price of $5 per share, with net proceeds after underwriting costs and associated expenses going toward providing working capital and helping with future costs of items like facility expansion or clinical studies. That came as a shock to investors, given that Organogenesis shares fetched $8 each as recently as three days ago. The company has lost money consistently for years, and today's drop shows the challenges for drug stocks in having to raise new capital at tough times.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

VirnetX Holding Corp Stock Quote
VirnetX Holding Corp
$2.69 (0.37%) $0.01
Pure Storage Stock Quote
Pure Storage
$31.60 (0.00%) $0.00
Organogenesis Inc. Stock Quote
Organogenesis Inc.
$9.54 (-0.83%) $0.08

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/05/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.